Skip to content
Search
Product Finder
My Cart
Checkout
Products
Close Products
Open Products
All Products →
Targeting Reagents
Tumor Cell Lines
Cellective™
G-Link CD3
Cell Lines
Lentiviral Vectors
Services
Close Services
Open Services
All Services →
Custom Cell Lines
Custom Vector Services
Assay Services
Contract Research
LV Cloning & Packing
AAV Cloning & Packaging
Lentiviral Vector Libraries
Vector Characterization
Vector Characterization
Cell-Based Virus Neutralization Assays
Molecular Assays
Multiplex Cytokine Immunoassays
Immunophenotyping
Vector Biodistribution
CAR-T Cell Characterization
Cell Proliferation & Killing Assays
Vector Targeting & Specificity
Tumor Model Validation
In Vivo Efficacy & Biodistribution
Platform Development
Resources
Close Resources
Open Resources
All Resources →
Order Information
About Us
Close About Us
Open About Us
Our Company
Careers
Products
Close Products
Open Products
All Products →
Targeting Reagents
Cellective™
G-Link CD3
Tumor Cell Lines
Cell Lines
Lentiviral Vectors
Services
Close Services
Open Services
All Services →
Custom Cell Lines
Custom Vector Services
LV Cloning & Packing
AAV Cloning & Packaging
Lentiviral Vector Libraries
Vector Characterization
Assay Services
Vector Characterization
Cell-Based Virus Neutralization Assays
Molecular Assays
Multiplex Cytokine Immunoassays
Immunophenotyping
Vector Biodistribution
CAR-T Cell Characterization
Cell Proliferation & Killing Assays
Vector Targeting & Specificity
Contract Research
Tumor Model Validation
In Vivo Efficacy & Biodistribution
Platform Development
Resources
Close Resources
Open Resources
All Resources →
Order Information
About Us
Close About Us
Open About Us
Our Company
Careers
Contact Us
My Cart
Checkout
Contact Us
Resources
Filter
Tags
Cell Lines
Contract Research
Custom Services
Immuno-oncology
Lentivirus Targeting
Category
Educational Resources
Flyers
Imanis Media
Posters and Presentations
Publications
Posters and Presentations
Apr 08 2026
Trimeric G-Linked Adaptors Bind Stably to Trimeric VSV-G Glycoproteins and Redirect the Entry Ofintravenously Administered Lentiviral Vectors for In Vivo CAR-T Therapy
Posters and Presentations
Apr 08 2026
VV169, an Intravenously Delivered, CD3-Targeted, Transcriptionally Regulated T-Cell Specific Vector Generates aBCMA-CAR-T Cells In Vivo and Efficiently Clears Disseminated Multiple Myeloma Tumors in a Preclinical Model